IN THE NEWS

« Previous Release | Next Release »

BOTHELL, Wash., -- Cardiac Science Corporation, a global leader in automated external defibrillator (AED) and diagnostic cardiac monitoring devices that connect to electronic medical record (EMR) and hospital information systems, today announced a partnership with eClinicalWorks, a leading provider of EMR systems.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080306/AQTH510LOGO)

As a result of this partnership, 30,000 eClinicalWorks physician users across 5,000 medical practices now have the ability to connect their Quinton and Burdick ECG, cardiac stress test, and Holter systems with the eClinicalWorks EMR. Similarly, Cardiac Science's installed customer base of more than 65,000 diagnostic monitoring devices can connect with eClinicalWorks and be assured the test results will flow smoothly into the medical record system.

"Our physician customers want Cardiac Science's market-leading cardiac monitoring devices to connect with leading EMRs," said Dave Marver, Cardiac Science president and chief executive officer. "This partnership gives our large existing customer base the opportunity to choose eClinicalWorks as their practice EMR."

Using Cardiac Science's HeartCentrix(R) connectivity solution, physicians will have the ability to send data from their diagnostic and monitoring devices into the eClinicalWorks EMR. The HeartCentrix solution can be installed with either a new eClinicalWorks EMR implementation or into an existing eClinicalWorks system.

eClinicalWorks CEO Girish Kumar Navani added, "Partnering with Cardiac Science, makes great business sense as it is a leader in diagnostic and cardiology devices, bringing ECG, Holter, cardiac stress and automated external defibrillator products into the physician office. With our partnership, each existing and new Cardiac Science customer has another reason to confidently choose eClinicalWorks for their EMR solution."

About Cardiac Science

Cardiac Science, a wholly owned subsidiary of Opto Circuits (India) Ltd., develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators (AED), electrocardiograph devices (ECG/EKG), cardiac stress treadmill and systems, PC-based diagnostic workstations, Holter monitoring systems, hospital defibrillators, vital signs monitors, cardiac rehabilitation telemetry systems, and cardiology data management systems (informatics) that connect with hospital information (HIS), electronic medical record (EMR), and other information systems. The company sells a variety of related products and consumables and provides a portfolio of training, maintenance, and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick^®, HeartCentrix^®, Powerheart^®, and Quinton^® brands, is headquartered in Bothell, Washington. With customers in almost 100 countries worldwide, the company has operations in North America, Europe, and Asia. For information, call 425.402.2000 or visit http://www.cardiacscience.com.

Forward-Looking Statements

This press release contains forward-looking statements. The words "believe," "expect," "intend," "anticipate," variations of such words, and similar expressions identify forward-looking statements, but their absence does not mean that the statement is not forward-looking. Forward-looking statements in this press release include, but are not limited to, those relating to Cardiac Science Corporation's future AED sales in Japan, expected shipments of backordered products in the fourth quarter of 2010, and expectations regarding the closing of the transaction with Opto Circuits. These are forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results and performance may vary significantly from those expressed or implied in such statements. Factors that could cause or contribute to such varying results and other risks include those more fully described in the Annual Report on Form 10-K filed by Cardiac Science Corporation for the year ended December 31, 2009, as updated by subsequent quarterly reports on Form 10-Q. Cardiac Science Corporation undertakes no duty or obligation to update the information provided herein.

For updates and information on worldwide defibrillation and cardiac monitoring, find us on Facebook at http://facebook.com/cardiacscience, the Cardiac Science blog at http://www.cardiacscience.com/blog, Twitter at http://twitter.com/cardiacscience, and YouTube at http://budurl.com/CSonYT

For more information, contact (media) info@cardiacscience.com | (investors) ir@optoindia.com | +91.80.2852.8088